Literature DB >> 25652543

Origin and proliferation of multiple-drug resistance in bacterial pathogens.

Hsiao-Han Chang1, Ted Cohen2, Yonatan H Grad3, William P Hanage1, Thomas F O'Brien4, Marc Lipsitch5.   

Abstract

SUMMARY: Many studies report the high prevalence of multiply drug-resistant (MDR) strains. Because MDR infections are often significantly harder and more expensive to treat, they represent a growing public health threat. However, for different pathogens, different underlying mechanisms are traditionally used to explain these observations, and it is unclear whether each bacterial taxon has its own mechanism(s) for multidrug resistance or whether there are common mechanisms between distantly related pathogens. In this review, we provide a systematic overview of the causes of the excess of MDR infections and define testable predictions made by each hypothetical mechanism, including experimental, epidemiological, population genomic, and other tests of these hypotheses. Better understanding the cause(s) of the excess of MDR is the first step to rational design of more effective interventions to prevent the origin and/or proliferation of MDR.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652543      PMCID: PMC4402963          DOI: 10.1128/MMBR.00039-14

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  118 in total

Review 1.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

Review 2.  Molecular mechanisms of antibacterial multidrug resistance.

Authors:  Michael N Alekshun; Stuart B Levy
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

3.  The influence of hitchhiking and deleterious mutation upon asexual mutation rates.

Authors:  Michael E Palmer; Marc Lipsitch
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

4.  Functional classification of drugs by properties of their pairwise interactions.

Authors:  Pamela Yeh; Ariane I Tschumi; Roy Kishony
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

Review 5.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

6.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

7.  Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction.

Authors:  V I Enne; D M Livermore; P Stephens; L M Hall
Journal:  Lancet       Date:  2001-04-28       Impact factor: 79.321

8.  Characterization of fluoroquinolone resistance mechanisms and their correlation with the degree of resistance to clinically used fluoroquinolones among Escherichia coli isolates.

Authors:  Tsung-Ming Chang; Po-Liang Lu; Hsuan-Hui Li; Chung-Yu Chang; Tun-Chieh Chen; Lin-Li Chang
Journal:  J Chemother       Date:  2007-10       Impact factor: 1.714

9.  Population structure and eigenanalysis.

Authors:  Nick Patterson; Alkes L Price; David Reich
Journal:  PLoS Genet       Date:  2006-12       Impact factor: 5.917

10.  Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.

Authors:  Suzanne M Hingley-Wilson; Rosalyn Casey; David Connell; Samuel Bremang; Jason T Evans; Peter M Hawkey; Grace E Smith; Annette Jepson; Stuart Philip; Onn Min Kon; Ajit Lalvani
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

View more
  59 in total

1.  Shigella flexneri serotype 3a: the rise of a superbug.

Authors:  Hervé Agaisse
Journal:  Lancet Infect Dis       Date:  2015-04-27       Impact factor: 25.071

2.  Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues.

Authors:  Takashi Misawa; Chihiro Goto; Norihito Shibata; Motoharu Hirano; Yutaka Kikuchi; Mikihiko Naito; Yosuke Demizu
Journal:  Medchemcomm       Date:  2019-04-04       Impact factor: 3.597

3.  Reduction in antimicrobial resistance by the way of extensive vaccination.

Authors:  Sachin Kumar
Journal:  Hum Vaccin Immunother       Date:  2018-08-17       Impact factor: 3.452

4.  Analysis of Multidrug Resistance in Staphylococcus aureus with a Machine Learning-Generated Antibiogram.

Authors:  Casey L Cazer; Lars F Westblade; Matthew S Simon; Reed Magleby; Mariana Castanheira; James G Booth; Stephen G Jenkins; Yrjö T Gröhn
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 5.  Population genomics of Klebsiella pneumoniae.

Authors:  Kelly L Wyres; Margaret M C Lam; Kathryn E Holt
Journal:  Nat Rev Microbiol       Date:  2020-02-13       Impact factor: 60.633

6.  The Search for Herbal Antibiotics: An In-Silico Investigation of Antibacterial Phytochemicals.

Authors:  Mary Snow Setzer; Javad Sharifi-Rad; William N Setzer
Journal:  Antibiotics (Basel)       Date:  2016-09-12

7.  Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.

Authors:  Karla D Passalacqua; Marie-Eve Charbonneau; Nicholas J Donato; Hollis D Showalter; Duxin Sun; Bo Wen; Miao He; Hanshi Sun; Mary X D O'Riordan; Christiane E Wobus
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

8.  Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.

Authors:  Tatiana Johnston; Gabriel Lambert Hendricks; Steven Shen; Roy Fangxing Chen; Bumsup Kwon; Michael John Kelso; Wooseong Kim; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-09-21       Impact factor: 3.808

9.  Photoexcited quantum dots for killing multidrug-resistant bacteria.

Authors:  Colleen M Courtney; Samuel M Goodman; Jessica A McDaniel; Nancy E Madinger; Anushree Chatterjee; Prashant Nagpal
Journal:  Nat Mater       Date:  2016-01-18       Impact factor: 43.841

10.  Price equation captures the role of drug interactions and collateral effects in the evolution of multidrug resistance.

Authors:  Erida Gjini; Kevin B Wood
Journal:  Elife       Date:  2021-07-22       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.